| Eric M Spickler, MD | |
|
Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202 | |
| (313) 916-2436 | |
| Not Available |
| Full Name | Eric M Spickler |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 45 Years |
| Location | Henry Ford Health System, Detroit, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730257478 | NPI | - | NPPES |
| ES048263 | Other | CHAMPUS-CHAMPUS | |
| ES048263 | Other | COMMERCIAL-COMMERCIAL NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085N0700X | Radiology - Neuroradiology | 4301048263 (Michigan) | Primary |
| 2085R0202X | Radiology - Diagnostic Radiology | 4301048263 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Henry Ford Hospital | Detroit, MI | Hospital |
| Henry Ford West Bloomfield Hospital | West bloomfield, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Henry Ford Medical Group | 0547178311 | 2095 |
| Beaumont Medical Group Hospital Based Services | 3072875889 | 457 |
News Archive
Tengion, Inc., a regenerative medicine company focused on discovering, developing, manufacturing and commercializing neo-organs and neo-tissues, today announced the completion of its initial public offering of 6,000,000 shares of common stock at a price of $5.00 per share. The net proceeds of the offering to Tengion, after deducting underwriting discounts and commissions and estimated offering expenses payable by Tengion, were approximately $26.0 million.
We all love our sugar, especially during the holidays. Cookies, cake, and candy are simply irresistible. While sugar cravings are common, the physiological mechanisms that trigger our "sweet tooth" are not well defined.
Intellipharmaceutics International Inc. today announced that it has received purchase agreement commitments from institutional investors to provide the Company with approximately US$12,000,000 in gross proceeds through the sale of its common stock and warrants.
One of the most complex medical imaging systems ever developed which uses proton beams to create 3D images of the internal anatomy of cancer patients will be installed in one of the UK's only two new NHS high energy proton beam therapy centers, helping to provide better treatment planning and monitoring for difficult to treat cancers.
› Verified 5 days ago
| Entity Name | Henry Ford Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134144801 PECOS PAC ID: 0547178311 Enrollment ID: O20031105000139 |
News Archive
Tengion, Inc., a regenerative medicine company focused on discovering, developing, manufacturing and commercializing neo-organs and neo-tissues, today announced the completion of its initial public offering of 6,000,000 shares of common stock at a price of $5.00 per share. The net proceeds of the offering to Tengion, after deducting underwriting discounts and commissions and estimated offering expenses payable by Tengion, were approximately $26.0 million.
We all love our sugar, especially during the holidays. Cookies, cake, and candy are simply irresistible. While sugar cravings are common, the physiological mechanisms that trigger our "sweet tooth" are not well defined.
Intellipharmaceutics International Inc. today announced that it has received purchase agreement commitments from institutional investors to provide the Company with approximately US$12,000,000 in gross proceeds through the sale of its common stock and warrants.
One of the most complex medical imaging systems ever developed which uses proton beams to create 3D images of the internal anatomy of cancer patients will be installed in one of the UK's only two new NHS high energy proton beam therapy centers, helping to provide better treatment planning and monitoring for difficult to treat cancers.
› Verified 5 days ago
| Entity Name | Henry Ford Macomb Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134265986 PECOS PAC ID: 7911808381 Enrollment ID: O20040119000142 |
News Archive
Tengion, Inc., a regenerative medicine company focused on discovering, developing, manufacturing and commercializing neo-organs and neo-tissues, today announced the completion of its initial public offering of 6,000,000 shares of common stock at a price of $5.00 per share. The net proceeds of the offering to Tengion, after deducting underwriting discounts and commissions and estimated offering expenses payable by Tengion, were approximately $26.0 million.
We all love our sugar, especially during the holidays. Cookies, cake, and candy are simply irresistible. While sugar cravings are common, the physiological mechanisms that trigger our "sweet tooth" are not well defined.
Intellipharmaceutics International Inc. today announced that it has received purchase agreement commitments from institutional investors to provide the Company with approximately US$12,000,000 in gross proceeds through the sale of its common stock and warrants.
One of the most complex medical imaging systems ever developed which uses proton beams to create 3D images of the internal anatomy of cancer patients will be installed in one of the UK's only two new NHS high energy proton beam therapy centers, helping to provide better treatment planning and monitoring for difficult to treat cancers.
› Verified 5 days ago
| Entity Name | Troy Internal Medicine, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356450589 PECOS PAC ID: 0840282067 Enrollment ID: O20040330001398 |
News Archive
Tengion, Inc., a regenerative medicine company focused on discovering, developing, manufacturing and commercializing neo-organs and neo-tissues, today announced the completion of its initial public offering of 6,000,000 shares of common stock at a price of $5.00 per share. The net proceeds of the offering to Tengion, after deducting underwriting discounts and commissions and estimated offering expenses payable by Tengion, were approximately $26.0 million.
We all love our sugar, especially during the holidays. Cookies, cake, and candy are simply irresistible. While sugar cravings are common, the physiological mechanisms that trigger our "sweet tooth" are not well defined.
Intellipharmaceutics International Inc. today announced that it has received purchase agreement commitments from institutional investors to provide the Company with approximately US$12,000,000 in gross proceeds through the sale of its common stock and warrants.
One of the most complex medical imaging systems ever developed which uses proton beams to create 3D images of the internal anatomy of cancer patients will be installed in one of the UK's only two new NHS high energy proton beam therapy centers, helping to provide better treatment planning and monitoring for difficult to treat cancers.
› Verified 5 days ago
| Entity Name | Beaumont Medical Group Hospital Based Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427567858 PECOS PAC ID: 3072875889 Enrollment ID: O20180314001796 |
News Archive
Tengion, Inc., a regenerative medicine company focused on discovering, developing, manufacturing and commercializing neo-organs and neo-tissues, today announced the completion of its initial public offering of 6,000,000 shares of common stock at a price of $5.00 per share. The net proceeds of the offering to Tengion, after deducting underwriting discounts and commissions and estimated offering expenses payable by Tengion, were approximately $26.0 million.
We all love our sugar, especially during the holidays. Cookies, cake, and candy are simply irresistible. While sugar cravings are common, the physiological mechanisms that trigger our "sweet tooth" are not well defined.
Intellipharmaceutics International Inc. today announced that it has received purchase agreement commitments from institutional investors to provide the Company with approximately US$12,000,000 in gross proceeds through the sale of its common stock and warrants.
One of the most complex medical imaging systems ever developed which uses proton beams to create 3D images of the internal anatomy of cancer patients will be installed in one of the UK's only two new NHS high energy proton beam therapy centers, helping to provide better treatment planning and monitoring for difficult to treat cancers.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric M Spickler, MD Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202 Ph: (313) 916-2436 | Eric M Spickler, MD Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202 Ph: (313) 916-2436 |
News Archive
Tengion, Inc., a regenerative medicine company focused on discovering, developing, manufacturing and commercializing neo-organs and neo-tissues, today announced the completion of its initial public offering of 6,000,000 shares of common stock at a price of $5.00 per share. The net proceeds of the offering to Tengion, after deducting underwriting discounts and commissions and estimated offering expenses payable by Tengion, were approximately $26.0 million.
We all love our sugar, especially during the holidays. Cookies, cake, and candy are simply irresistible. While sugar cravings are common, the physiological mechanisms that trigger our "sweet tooth" are not well defined.
Intellipharmaceutics International Inc. today announced that it has received purchase agreement commitments from institutional investors to provide the Company with approximately US$12,000,000 in gross proceeds through the sale of its common stock and warrants.
One of the most complex medical imaging systems ever developed which uses proton beams to create 3D images of the internal anatomy of cancer patients will be installed in one of the UK's only two new NHS high energy proton beam therapy centers, helping to provide better treatment planning and monitoring for difficult to treat cancers.
› Verified 5 days ago
Dr. Brent David Griffith, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Kanika Khanna, M.D Radiology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Dr. Michael Matthew Dominello, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 4100 John R, Detroit, MI 48201 Phone: 800-527-6266 Fax: 313-576-9640 | |
Rajinder P. Sharma, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202 Phone: 313-916-2436 | |
Milan V. Pantelic, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202 Phone: 313-916-2436 | |
Kristan Gail Jenkins-mosure, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 800-653-6568 | |
Kristin Booth, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 517-402-1383 |